External validation of risk classification in patients with docetaxel-treated castration-resistant prostate cancer

BACKGROUND: Castration-resistant prostate cancer (CRPC) patients have poor prognoses, and docetaxel (DTX) is among the few treatment options. An accurate risk classification to identify CRPC patient groups for which DTX would be effective is urgently warranted. The Armstrong risk classification (ARC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nakano, Kazuhiko, Komatsu, Kenji, Kubo, Taro, Natsui, Shinsuke, Nukui, Akinori, Kurokawa, Shinsuke, Kobayashi, Minoru, Morita, Tatsuo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3997751/
https://ncbi.nlm.nih.gov/pubmed/24742323
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2490-14-31
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados